Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep | 41 | 2025 | 465 | 5.320 |
Why?
|
| Sleep Deprivation | 23 | 2026 | 128 | 4.020 |
Why?
|
| Circadian Rhythm | 23 | 2026 | 295 | 3.660 |
Why?
|
| Sleep Apnea, Obstructive | 19 | 2021 | 229 | 3.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 21 | 2025 | 1286 | 2.860 |
Why?
|
| Blood Glucose | 23 | 2025 | 911 | 2.680 |
Why?
|
| Obesity | 22 | 2020 | 1061 | 2.400 |
Why?
|
| Sleep Wake Disorders | 15 | 2023 | 139 | 2.110 |
Why?
|
| Insulin Resistance | 12 | 2018 | 391 | 1.600 |
Why?
|
| Continuous Positive Airway Pressure | 3 | 2016 | 56 | 1.020 |
Why?
|
| Chronobiology Disorders | 2 | 2016 | 4 | 0.910 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2019 | 54 | 0.890 |
Why?
|
| Sleep, REM | 8 | 2014 | 49 | 0.890 |
Why?
|
| Hydrocortisone | 14 | 2024 | 305 | 0.870 |
Why?
|
| Human Growth Hormone | 7 | 2016 | 51 | 0.790 |
Why?
|
| Melatonin | 6 | 2024 | 47 | 0.780 |
Why?
|
| Glycerides | 2 | 2020 | 14 | 0.740 |
Why?
|
| Arachidonic Acids | 2 | 2020 | 37 | 0.740 |
Why?
|
| Endocannabinoids | 2 | 2020 | 28 | 0.730 |
Why?
|
| Diabetes, Gestational | 2 | 2013 | 51 | 0.700 |
Why?
|
| Polysomnography | 17 | 2017 | 154 | 0.680 |
Why?
|
| Circadian Clocks | 3 | 2021 | 69 | 0.640 |
Why?
|
| Insulin | 9 | 2017 | 1225 | 0.620 |
Why?
|
| Humans | 85 | 2026 | 98080 | 0.580 |
Why?
|
| Wakefulness | 6 | 2016 | 128 | 0.570 |
Why?
|
| Adult | 47 | 2026 | 29539 | 0.550 |
Why?
|
| Diabetes Mellitus | 6 | 2015 | 811 | 0.550 |
Why?
|
| Male | 56 | 2026 | 47076 | 0.540 |
Why?
|
| Blood Pressure | 6 | 2021 | 910 | 0.480 |
Why?
|
| Risk Factors | 19 | 2021 | 6233 | 0.470 |
Why?
|
| Neurosecretory Systems | 3 | 2008 | 36 | 0.450 |
Why?
|
| Female | 46 | 2026 | 51536 | 0.450 |
Why?
|
| Prediabetic State | 4 | 2021 | 43 | 0.430 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 148 | 0.430 |
Why?
|
| Appetite | 4 | 2009 | 21 | 0.430 |
Why?
|
| Glucocorticoids | 1 | 2017 | 370 | 0.420 |
Why?
|
| Time Factors | 16 | 2019 | 5567 | 0.410 |
Why?
|
| Leptin | 3 | 2020 | 101 | 0.410 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2011 | 196 | 0.410 |
Why?
|
| Health Status | 4 | 2005 | 385 | 0.400 |
Why?
|
| Middle Aged | 33 | 2025 | 29428 | 0.400 |
Why?
|
| Glucose Tolerance Test | 9 | 2019 | 239 | 0.400 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 101 | 0.390 |
Why?
|
| Occupational Diseases | 1 | 2014 | 58 | 0.390 |
Why?
|
| Aging | 4 | 2005 | 770 | 0.390 |
Why?
|
| Hormones | 2 | 2009 | 138 | 0.350 |
Why?
|
| Sleep Stages | 3 | 2010 | 45 | 0.340 |
Why?
|
| Young Adult | 15 | 2026 | 7507 | 0.330 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 143 | 0.330 |
Why?
|
| Metabolism | 1 | 2010 | 25 | 0.320 |
Why?
|
| Autonomic Nervous System | 3 | 2016 | 70 | 0.320 |
Why?
|
| Heart Rate | 3 | 2025 | 534 | 0.320 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 365 | 0.310 |
Why?
|
| Affect | 2 | 2015 | 410 | 0.310 |
Why?
|
| Aged | 23 | 2025 | 21758 | 0.310 |
Why?
|
| Testosterone | 1 | 2011 | 265 | 0.300 |
Why?
|
| Pregnancy Outcome | 1 | 2011 | 277 | 0.300 |
Why?
|
| Inpatients | 2 | 2016 | 369 | 0.300 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 802 | 0.290 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 462 | 0.280 |
Why?
|
| Brain | 3 | 2017 | 2430 | 0.280 |
Why?
|
| Growth Hormone | 3 | 2005 | 96 | 0.270 |
Why?
|
| Glucose | 6 | 2021 | 704 | 0.270 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1995 | 0.260 |
Why?
|
| Dietary Carbohydrates | 2 | 2010 | 39 | 0.250 |
Why?
|
| Hunger | 2 | 2016 | 22 | 0.250 |
Why?
|
| Cross-Sectional Studies | 9 | 2024 | 2037 | 0.240 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 3022 | 0.240 |
Why?
|
| Cross-Over Studies | 7 | 2026 | 409 | 0.230 |
Why?
|
| Delta Rhythm | 1 | 2005 | 18 | 0.230 |
Why?
|
| Pituitary-Adrenal System | 3 | 2017 | 69 | 0.230 |
Why?
|
| Metabolome | 1 | 2026 | 70 | 0.220 |
Why?
|
| Epinephrine | 1 | 2005 | 91 | 0.220 |
Why?
|
| Respiratory Rate | 1 | 2025 | 26 | 0.220 |
Why?
|
| Fasting | 5 | 2016 | 166 | 0.220 |
Why?
|
| Peptide Hormones | 1 | 2004 | 30 | 0.210 |
Why?
|
| Critical Illness | 3 | 2023 | 436 | 0.210 |
Why?
|
| Bradycardia | 1 | 2025 | 51 | 0.210 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 5 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2017 | 269 | 0.200 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2015 | 12 | 0.200 |
Why?
|
| Vaccination | 2 | 2023 | 323 | 0.200 |
Why?
|
| Retinal Ganglion Cells | 1 | 2024 | 73 | 0.200 |
Why?
|
| Diabetic Retinopathy | 1 | 2024 | 81 | 0.190 |
Why?
|
| Congresses as Topic | 2 | 2021 | 123 | 0.190 |
Why?
|
| Body Mass Index | 5 | 2017 | 850 | 0.190 |
Why?
|
| Electroencephalography | 5 | 2017 | 789 | 0.190 |
Why?
|
| Adolescent | 11 | 2023 | 10080 | 0.180 |
Why?
|
| Vaccines | 1 | 2023 | 86 | 0.180 |
Why?
|
| Meals | 1 | 2021 | 23 | 0.170 |
Why?
|
| Research Report | 1 | 2021 | 43 | 0.170 |
Why?
|
| Influenza Vaccines | 1 | 2002 | 176 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2002 | 338 | 0.160 |
Why?
|
| Energy Metabolism | 3 | 2015 | 315 | 0.160 |
Why?
|
| Actigraphy | 5 | 2025 | 69 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2023 | 7389 | 0.160 |
Why?
|
| Hospitalization | 2 | 2016 | 991 | 0.150 |
Why?
|
| Fatigue | 2 | 2011 | 187 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 2 | 2017 | 299 | 0.150 |
Why?
|
| Exercise | 1 | 2003 | 380 | 0.150 |
Why?
|
| Prevalence | 4 | 2014 | 1384 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 108 | 0.140 |
Why?
|
| Prospective Studies | 7 | 2017 | 4823 | 0.140 |
Why?
|
| Phototherapy | 1 | 2018 | 33 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2026 | 661 | 0.140 |
Why?
|
| Ghrelin | 2 | 2010 | 31 | 0.140 |
Why?
|
| Attention | 1 | 2003 | 435 | 0.140 |
Why?
|
| Jet Lag Syndrome | 4 | 2019 | 13 | 0.130 |
Why?
|
| Social Class | 1 | 1999 | 156 | 0.130 |
Why?
|
| Thyroid Gland | 1 | 2019 | 297 | 0.130 |
Why?
|
| Hyperglycemia | 2 | 2016 | 186 | 0.130 |
Why?
|
| Habits | 1 | 2017 | 17 | 0.130 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2017 | 40 | 0.130 |
Why?
|
| Carbohydrate Metabolism | 2 | 2008 | 31 | 0.120 |
Why?
|
| Animals | 9 | 2021 | 28894 | 0.120 |
Why?
|
| Poverty | 1 | 1999 | 215 | 0.120 |
Why?
|
| Time | 1 | 2016 | 80 | 0.120 |
Why?
|
| Norepinephrine | 1 | 2016 | 167 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2016 | 39 | 0.120 |
Why?
|
| Hyperphagia | 1 | 2016 | 36 | 0.120 |
Why?
|
| Treatment Outcome | 4 | 2017 | 9711 | 0.120 |
Why?
|
| Pregnancy | 2 | 2013 | 3244 | 0.110 |
Why?
|
| Comorbidity | 3 | 2015 | 1033 | 0.110 |
Why?
|
| Hormone Replacement Therapy | 2 | 2013 | 104 | 0.110 |
Why?
|
| Hypertension | 3 | 2014 | 778 | 0.110 |
Why?
|
| Lighting | 2 | 2012 | 31 | 0.100 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2008 | 83 | 0.100 |
Why?
|
| Sex Factors | 4 | 2010 | 1138 | 0.100 |
Why?
|
| Snoring | 2 | 2017 | 12 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 239 | 0.100 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2013 | 72 | 0.100 |
Why?
|
| Hypopituitarism | 1 | 2013 | 17 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 445 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 328 | 0.100 |
Why?
|
| Brain Waves | 1 | 2013 | 33 | 0.090 |
Why?
|
| Energy Intake | 1 | 2013 | 99 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 208 | 0.090 |
Why?
|
| Biomarkers | 2 | 2023 | 2020 | 0.090 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 64 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2017 | 124 | 0.090 |
Why?
|
| Logistic Models | 2 | 2016 | 1275 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1123 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2015 | 234 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2019 | 3212 | 0.090 |
Why?
|
| Healthy Volunteers | 3 | 2017 | 153 | 0.090 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 70 | 0.090 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 72 | 0.080 |
Why?
|
| Adipocytes | 1 | 2012 | 180 | 0.080 |
Why?
|
| Child | 3 | 2019 | 7681 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2007 | 985 | 0.080 |
Why?
|
| Age Factors | 4 | 2010 | 1962 | 0.080 |
Why?
|
| Thyrotropin | 3 | 2010 | 328 | 0.080 |
Why?
|
| Random Allocation | 2 | 2017 | 311 | 0.080 |
Why?
|
| Postprandial Period | 2 | 2010 | 44 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2012 | 527 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 571 | 0.070 |
Why?
|
| Prolactin | 2 | 2005 | 90 | 0.070 |
Why?
|
| Quality of Life | 2 | 2010 | 1895 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2010 | 256 | 0.070 |
Why?
|
| Vagus Nerve | 2 | 2005 | 46 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2012 | 520 | 0.070 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 125 | 0.070 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 100 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 134 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1120 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2016 | 889 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10973 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2013 | 0.060 |
Why?
|
| Acetamides | 1 | 2005 | 27 | 0.060 |
Why?
|
| Alpha Rhythm | 1 | 2005 | 28 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2006 | 578 | 0.060 |
Why?
|
| Body Temperature | 1 | 2005 | 127 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 109 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2007 | 350 | 0.050 |
Why?
|
| Homeostasis | 3 | 2015 | 474 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2004 | 117 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1012 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 699 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 172 | 0.050 |
Why?
|
| Somatoform Disorders | 1 | 2002 | 31 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 313 | 0.040 |
Why?
|
| Loneliness | 1 | 2002 | 33 | 0.040 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1981 | 2 | 0.040 |
Why?
|
| Heart | 1 | 2004 | 527 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 2585 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 480 | 0.040 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2000 | 7 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 663 | 0.040 |
Why?
|
| Seasons | 1 | 1981 | 251 | 0.040 |
Why?
|
| Geriatric Assessment | 2 | 2015 | 193 | 0.040 |
Why?
|
| Overweight | 1 | 2019 | 123 | 0.030 |
Why?
|
| Area Under Curve | 2 | 2010 | 340 | 0.030 |
Why?
|
| Incidence | 2 | 2014 | 1779 | 0.030 |
Why?
|
| Adiposity | 1 | 2017 | 79 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 355 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 204 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2784 | 0.030 |
Why?
|
| Appetite Regulation | 1 | 2016 | 7 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2015 | 23 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 980 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 977 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 164 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1009 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 922 | 0.030 |
Why?
|
| Accelerometry | 1 | 2015 | 49 | 0.030 |
Why?
|
| Wisconsin | 1 | 2014 | 45 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 193 | 0.030 |
Why?
|
| Arousal | 2 | 2008 | 177 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 367 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 92 | 0.030 |
Why?
|
| C-Peptide | 1 | 1994 | 191 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 391 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 4071 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 383 | 0.020 |
Why?
|
| Reward | 1 | 2016 | 226 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 162 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 1610 | 0.020 |
Why?
|
| Kinetics | 1 | 1994 | 1476 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 878 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 370 | 0.020 |
Why?
|
| Acylation | 1 | 2010 | 68 | 0.020 |
Why?
|
| Chicago | 1 | 2015 | 1513 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 131 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2010 | 146 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 471 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 66 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 608 | 0.020 |
Why?
|
| Health Surveys | 1 | 2010 | 254 | 0.020 |
Why?
|
| Life Style | 1 | 2010 | 193 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1950 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 726 | 0.020 |
Why?
|
| Glucaric Acid | 1 | 2005 | 5 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2005 | 54 | 0.010 |
Why?
|
| Neoplasms | 1 | 2021 | 3334 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2005 | 43 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2005 | 109 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 263 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 3620 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 12698 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 1782 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 139 | 0.010 |
Why?
|
| Health Behavior | 1 | 2002 | 200 | 0.010 |
Why?
|
| Students | 1 | 2002 | 196 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2002 | 349 | 0.010 |
Why?
|
| United States | 1 | 2010 | 8197 | 0.010 |
Why?
|